Screening for sul1 and HemO gene in Stenotrophomonas maltophilia isolated from Patients in Iraq
DOI:
https://doi.org/10.69923/IJAS.2024.010106Keywords:
Sul1 gene, HemO gene, Stenotrophomonas maltophiliaAbstract
The opportunistic pathogen Stenotrophomonas maltophilia can be isolated in hospitals which is naturally resist to many common antibiotics, such as carbapenems and aminoglycosides. Current study involving 120 urine samples (included prostate cancer patient, bladder cancer patient, renal filer patient in addition to UTI infection patient) collected from Ghazi AL-Hariri Hospital/Medical City Hospital and AL-Amal National Cancer Hospital, Baghdad, Iraq, all urine samples were primary cultured on MacConkey, UTI media and blood agar as well as a selective and differential medium for S. maltophilia growth called VIA which contain (vancomycin, imipenem, and amphotericin B). Studying their antibiotic susceptibility pattern using Vitek 2 compact system and screening for presence of virulence genes using polymerase chain reaction technique. The results showed only 87 (72.5%) from total samples were give bacterial growth, involving various bacterial species. Stenotrophomonas percentage was 7/87(8%) of total bacteria growth, which show high resistance percentage to sulfonamide antibiotic 85.7%. the ratio of isolates carrying sul 1 gene was 7/7 (100%) and HemO gene was 3/7 (42.8%) so looking for new effective antibiotics could be an ideal course of treatment for infections owned to S. maltophilia, especially in patients who are critically sick and immunocompromised.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Iraqi Journal for Applied Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licenses and Copyright
The copyright of this article is retained by the author(s).
This article is published by the Iraqi Journal for Applied Science (IJAS) under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
This license permits unrestricted use, distribution, reproduction, adaptation, and reuse of the work in any medium or format, including commercial use, provided that appropriate credit is given to the original author(s) and the source, a link to the license is provided, and any modifications are indicated.
Authors retain full copyright of their work and grant IJAS a non-exclusive license to publish, archive, preserve, and disseminate the article, including registration of metadata and Digital Object Identifiers (DOIs) through Crossref.
Any third-party material included in this article remains subject to its respective copyright and licensing conditions. Authors are responsible for obtaining all necessary permissions for such material before publication.
For complete details regarding copyright, licensing, permissions, and reuse, please refer to the journal's Copyright and Licensing Policy available on the IJAS website.
License: https://creativecommons.org/licenses/by/4.0/



